Skip to content
OpenCapital
Get started

Aquestive Therapeutics, Inc. AQST Debt-to-equity

Debt-to-equity at other companies

ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
1.6×+1.6×
Viatris logo
ViatrisVTRS
1×+0.1×
AptarGroup logo
AptarGroupATR
0.5×+0.1×
AbbVie logo
AbbVieABBV
46.6×+38.6×
Regenxbio logo
RegenxbioRGNX
3.4×+3.1×
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
0×0.0×

Other financials

Income statement

See full
Revenue$14.4M+65.7%
Gross profit$11.0M+117%
Operating income-$4.2M+78.3%
Net income-$8.1M+64.9%
EPS (diluted)-$0.07+70.8%

Balance sheet

See full
Cash & equivalents$110.7M+61.3%
Total debt$64.4M+7.4%
Total equity-$34.1M+44.1%
Total assets$141.1M+38.0%

Cash flow

See full
Operating cash flow-$14.8M+36.7%
CapEx$52.0K-61.5%
Free cash flow-$14.9M+36.9%

Valuation

See full
Market cap$560.13M+73.5%
Enterprise value$513.76M+63.6%
P/S11.1×+5.2×

Profitability

See full
Gross margin63.5%-4.9pp
Operating margin-111.2%+96.3pp
Net margin-137.1%+80.7pp
FCF margin-88.2%-2.2pp

Returns & leverage

See full
Return on equity145.1%—
Current ratio4.1×-0.8×